TRT in your 20s: what the risks evidence actually shows

What did @gc.bioscience actually say?

The creator's core argument is straightforward: men in their 20s should not take TRT because testosterone naturally peaks during that decade, and adding exogenous testosterone can cause lasting hormonal disruption, cardiovascular harm, and metabolic damage. The framing is directed squarely at gym culture, calling out the old habit of sourcing testosterone from "gym bags."

Specifically, the creator warned that even modest TRT doses can "mess you up for a very, very long time, if not forever." They also flagged cardiovascular risk, arguing that testosterone raises red blood cell production, thickens the blood, and combined with a poor cholesterol profile, increases what they called "atherogenic risk." The mechanism they described involves erythrocytosis plus elevated circulating cholesterol contributing to arterial plaque buildup. It's a lot to pack into a short clip, and most of it is directionally correct, though some of the language is imprecise in ways that matter clinically.

Does the science back this up?

Mostly yes, with important caveats. The claim that testosterone peaks in the 20s is well-supported. The cardiovascular risk argument has real evidence behind it, though the mechanism was oversimplified in ways that could confuse viewers.

Testosterone does peak in early adulthood. Data from the European Male Ageing Study (Wu et al., 2010, Journal of Clinical Endocrinology and Metabolism) confirm that total testosterone levels decline progressively after approximately age 30 to 35. Using exogenous testosterone in a young man with normal hypothalamic-pituitary-gonadal (HPG) axis function suppresses LH and FSH via negative feedback, which can cause testicular atrophy and impair spermatogenesis. Recovery after stopping TRT is not guaranteed, particularly after prolonged use. Rahnema et al. (2014, Fertility and Sterility) documented cases of exogenous androgen-induced hypogonadism that persisted long after cessation, including in young men who used performance-enhancing doses.

On cardiovascular risk, the erythrocytosis concern is real. Testosterone stimulates erythropoiesis through EPO upregulation, and elevated hematocrit increases blood viscosity, which is an established cardiovascular risk factor. The cholesterol picture is more complex than the creator implied, but the directional concern holds.

What did they get right and wrong?

The creator got the core warning right. Healthy 20-year-olds with normal testosterone have no clinical indication for TRT, and using it anyway carries genuine risks to fertility, hormonal function, and cardiovascular health. That's accurate and worth saying plainly.

Where the explanation gets sloppy is the cholesterol claim. The creator said testosterone causes you to "lay down plaque" because it makes "red blood cells thicc up" and there's "all this cholesterol buzzing around the archers." That conflates two separate mechanisms. Erythrocytosis raises hematocrit and blood viscosity, which is one risk pathway. Lipid effects are a different pathway entirely. Supraphysiologic androgens, particularly oral or 17-alpha-alkylated forms, do suppress HDL and can raise LDL (Zmuda et al., 1993, Metabolism). Injectable testosterone has a more modest lipid impact at replacement doses, though supraphysiologic doses are another matter. Combining both mechanisms into one blurry explanation of "thicc blood plus cholesterol" is the kind of shorthand that sounds scary and isn't entirely wrong, but it's not how the pathophysiology actually works. A viewer could walk away with a fundamentally muddled understanding of why TRT carries cardiovascular risk.

What should you actually know?

If you are a man in your 20s experiencing symptoms like fatigue, low libido, or poor recovery, the answer is not to self-prescribe TRT from an unregulated source. It is to get a proper workup. True primary or secondary hypogonadism can occur in young men and does warrant clinical evaluation and, in some cases, treatment. The creator's video could be read as implying TRT is never appropriate in your 20s, which is not accurate medicine.

What the evidence actually supports is this: TRT in young men without confirmed hypogonadism carries real risks to fertility and long-term hormonal function, and those risks are not justified by the performance or body composition benefits. The Endocrine Society's clinical practice guidelines specify that TRT should not be initiated without biochemical confirmation of hypogonadism and should be used with caution in men who wish to preserve fertility. Clomiphene citrate or hCG-based protocols are sometimes used in younger hypogonadal men specifically to preserve testicular function, which TRT does not do. That nuance was entirely absent from this video.

• Get bloodwork, including total testosterone, free testosterone, LH, FSH, and a metabolic panel, before drawing any conclusions about your hormone status.
• Symptoms alone are not a diagnosis. Many causes of fatigue, low libido, and poor performance in young men are unrelated to testosterone.
• If TRT is clinically indicated, it should be managed by a licensed provider, not sourced informally.